Avadel Pharmaceuticals to Participate in Fireside Chats at Upcoming March 2021 Investor Conferences

Rhea-AI Summary

Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced participation in fireside chats at the H.C. Wainwright Global Life Sciences Conference on March 9, 2021 and the Oppenheimer 31st Annual Healthcare Conference on March 17, 2021. The management team will discuss the company's investigational drug, FT218, a once-nightly formulation of sodium oxybate for treating narcolepsy-related symptoms. Webcasts of these events will be available on the company's website for 90 days following the presentations.

DUBLIN, Ireland, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in adults with narcolepsy, announced today that members of the Avadel management team will participate in fireside chats at the H.C. Wainwright Global Life Sciences Conference and Oppenheimer 31st Annual Healthcare Conference which are being held in March 2021.

Fireside Chat Details:
Event:	H.C. Wainwright Global Life Sciences Conference
Date:	March 9th
Webcast:	A webcast of this event will be available starting at 7 a.m. ET on Tuesday, March 9th, at (click here), as well as on Avadel’s website, www.avadel.com, with an archive available for 90 days.
Event:	Oppenheimer 31st Annual Healthcare Conference
Time and Date:	3:10 p.m. ET on Wednesday, March 17th
Webcast:	A live webcast of this event, as well as an archived recording, will be available at (click here), as well as on Avadel’s website, www.avadel.com, for 90 days from being made available.

Contacts:

	Tom McHugh
	Chief Financial Officer
	Phone: (636) 449-1843
	Email: tmchugh@avadel.com
	Tim McCarthy
	LifeSci Advisors, LLC
	Phone: (212) 915-2564
	Email: tim@lifesciadvisors.com

FAQ

What is the purpose of Avadel Pharmaceuticals participating in the March 2021 conferences?

Avadel Pharmaceuticals is participating in the conferences to discuss their investigational drug FT218 for narcolepsy.

When will Avadel present at the H.C. Wainwright Global Life Sciences Conference?

Avadel will present at the H.C. Wainwright Global Life Sciences Conference on March 9, 2021.

What time is Avadel's presentation at the Oppenheimer 31st Annual Healthcare Conference?

Avadel's presentation at the Oppenheimer 31st Annual Healthcare Conference is scheduled for 3:10 p.m. ET on March 17, 2021.

Where can I find the webcasts of Avadel's conference presentations?

The webcasts will be available on Avadel's website and will remain accessible for 90 days after the events.

What is FT218 that Avadel Pharmaceuticals is discussing at these conferences?

FT218 is an investigational once-nightly formulation of sodium oxybate aimed at treating excessive daytime sleepiness and cataplexy in adults with narcolepsy.